DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Education Anti vegf

1. Anti-VEGF “Other” uses 39th Annual All Gujarat Ophthalmology confSaturday 24th Sept 2011 Sep 24, 2011 11.45 am to 1.15 pmHallCDr. AnandSudhalkarVadodara9/23/20111…

Documents (PowerPoint)

1. GBM David Tran Grand Rounds 1/9/09 2. No disclosures to report 3. GBM GOOGLED GBM Isle of Man (International Auto Identification) GBM Glioblastoma Multiforme GBM Glomerular…

Education Treatment of Ovarian Cancer First Line Chemotherapy or Targeted Therapy for Recurrent Cases

Ovarian cancer is the seventh most common gynecological cancer worldwide, ovarian cancer is the eighth leading cause of cancer death in women. Takuma Hayashi | Kaoru

Documents Bevacizumab Therapy in Patients with Recurrent Uterine Neoplasms

8258WRIGHTAbstract. Background: Angiogenesis plays an important role in endometrial carcinogenesis. We reviewed our experience with the anti-VEGF monoclonal antibody bevacizumab

Documents Treatment of Hereditary Hemorrhagic Telangiec tasia –Rela ted Epis taxis

Treatment of Hereditary Hemorrhagic Telangiectasia-Related EpistaxisKEYWORDS KEY LEARNING POINTS At the end of this article, the reader will: Know how to diagnose a patient

Documents Effective Treatment for Malignant Pleural Effusion and Ascites with Combined Therapy of Bevacizumab....

5514J_PROTIPIARAbstract. Objective: To record the efficacy and toxicity of combining bevacizumab with cisplatin in treating malignant pleural effusion and ascites through

Documents EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma

LO EANO Guidelines Malignant Glioma Revised 2013-12-16-CLEAN.pdfZurich Open Repository and Archive University of Zurich University Library Strickhofstrasse 39 CH-8057 Zurich

Documents Neurofibromatosis tipos 1 y 2

115Neurofibromatosis tipos 1 y 2Correa M. F., et al. REVISIÓN Neurofibromatosis tipos 1 y 2 María Florencia Correa y Natalia Inés Pasik RESUMEN La neurofibromatosis

Documents Toxicity profile of bevacizumab in the UK Neurofibromatosis Type 2 cohort

2 cohort Morris, K.A., Golding, J.F., Blesing, C., Evans, D.G., Ferner, R.E., Foweraker, K., Halliday, D., Jena, R., McBain, C., McCabe, M.G., Swampillai, A., Warner, N.,

Documents Primer consenso mexicano sobre recomendaciones de la atención multidisciplinaria del paciente...

M.A. Celis, et al.: Primer consenso mexicano sobre glioblastoma multiforme 403 Primer consenso mexicano sobre recomendaciones de la atención multidisciplinaria del